Group-based Integrative Pain Management (IPMP+ Pilot)
CompletedNot applicableNCT05906784
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Socioeconomically disadvantaged populations have a high prevalence of chronic pain, exacerbated by social isolation, intersectional stigma, and disparities in pain assessment and treatment options. Effective interventions using a multilevel, biopsychosocial approach are needed to decrease the unequal burden of pain. The proposed pilot study will test group-based integrative models of pain management in primary care safety net clinics to improve pain care for racially and ethnically diverse low-income patients.
Study details
- Official title
- Pilot Phase of Group-based Integrative Pain Management: A Multi-level Approach to Address Intersectional Stigma and Social Isolation in Diverse Primary Care Safety Net Patients With Chronic Pain
- Conditions
- Interventions
- Other: group acupuncture
- Other: Integrative Group Medical Visits
- Sponsor
- University of California, San Francisco
- Collaborators
- National Institute on Minority Health and Health Disparities (NIMHD)
- Start date
- 2023-04-28
- Primary completion
- 2023-12-04
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * adults aged \> 18 * fluency in English or Spanish; * panelled to a primary care provider at one of the study clinics; * diagnosis of chronic pain (\> 3 months); * had a primary care visit for chronic pain within the past six months; * ability to provide a phone number; * able to participate in groups; * intent to be available for up to 24 weeks. Exclusion Criteria: * current anticoagulant use * active cancer treatment * inability to provide informed consent due to mental illness or cognitive impairment.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05906784